Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · Real-Time Price · USD

19.10

+0.34 (1.81%)

At close: Jul 29, 2026, 4:00 PM EDT

19.40

+0.30 (1.57%)

After-hours: Jul 29, 2026, 7:34 PM EDT

Amneal Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,046	3,019	2,794	2,394	2,212	2,094
Revenue Growth	7.62%	8.05%	16.73%	8.20%	5.67%	5.08%
Cost of Revenue	1,868	1,905	1,774	1,573	1,428	1,325
Gross Profit	1,178	1,113	1,020	820.57	784.71	768.97
Selling, General & Admin	547.4	526.83	476.44	429.68	399.7	365.5
Research & Development	191.93	193.81	196.56	198.58	213.02	210.27
Other Operating Expenses	-3.8	-1.42	98.12	-12.06	266.92	40.48
Total Operating Expenses	735.53	719.21	771.11	616.19	879.64	616.26
Operating Income	435.52	394.1	249.33	204.37	-94.93	152.72
Interest Expense	-237.51	-241.09	-258.6	-210.63	-158.38	-136.33
Other Non-Operating Income (Expense)	18.77	-13.8	-45.74	-34.02	5.18	14.98
Total Non-Operating Income (Expense)	-218.75	-254.89	-304.34	-244.64	-153.2	-121.35
Pretax Income	181.9	139.21	-55.01	-40.27	-248.13	31.37
Provision for Income Taxes	0.58	11.28	18.86	8.45	6.66	11.2
Net Income	181.32	127.93	-73.88	-48.72	-254.79	20.17
Minority Interest in Earnings	59.2	55.88	43.01	35.27	-124.8	9.55
Net Income to Common	122.12	72.06	-116.89	-83.99	-129.99	10.62
Net Income Growth	-	-	-	-	-	-88.33%
Shares Outstanding (Basic)	313	313	309	176	151	152
Shares Outstanding (Diluted)	321	325	309	176	151	152
Shares Change	3.31%	5.12%	75.42%	16.53%	-0.41%	1.67%
EPS (Basic)	0.39	0.23	-0.38	-0.48	-0.86	0.07
EPS (Diluted)	0.38	0.22	-0.38	-0.48	-0.86	0.07
EPS Growth	-	-	-	-	-	-88.52%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	207.26	241.15	234.76	298.78	16.31	190.88
Free Cash Flow Growth	-14.54%	2.72%	-21.43%	1732.42%	-91.46%	-39.82%
Free Cash Flow Per Share	0.64	0.74	0.76	1.70	0.11	1.26
Gross Margin	38.66%	36.88%	36.52%	34.28%	35.47%	36.73%
Operating Margin	14.30%	13.05%	8.92%	8.54%	-4.29%	7.29%
Profit Margin	5.95%	4.24%	-2.64%	-2.04%	-11.52%	0.96%
FCF Margin	6.80%	7.99%	8.40%	12.48%	0.74%	9.12%
EBITDA	642.13	617.67	485.52	433.77	145.25	386.12
EBITDA Margin	21.08%	20.46%	17.38%	18.12%	6.57%	18.44%
EBIT	435.52	394.1	249.33	204.37	-94.93	152.72
EBIT Margin	14.30%	13.05%	8.92%	8.54%	-4.29%	7.29%
Effective Tax Rate	0.32%	8.10%	-34.29%	-20.99%	-2.68%	35.69%

SEC Filings: 10-K · 10-Q